HB2949 EnrolledLRB103 27415 DTM 53787 b

1    AN ACT concerning State government.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Asthma Inhalers at Recreational Camps Act
5is amended by changing Sections 1, 5, and 10 as follows:
 
6    (410 ILCS 607/1)
7    Sec. 1. Short title. This Act may be cited as the Emergency
8Asthma Inhalers and Allergy Treatment for Children at
9Recreational Camps Act.
10(Source: P.A. 94-670, eff. 8-23-05.)
 
11    (410 ILCS 607/5)
12    Sec. 5. Definitions. In this Act:
13    "After-school care program" means an after-school care
14program operated by a park district or any nonprofit entity.
15    "Recreational camp" means any place set apart for
16recreational purposes for boys and girls. "Recreational camp"
17shall not apply to private camps owned or leased for
18individual or family use, or to any camp operated for a period
19of less than 10 days in a year.
20(Source: P.A. 94-670, eff. 8-23-05.)
 
21    (410 ILCS 607/10)

 

 

HB2949 Enrolled- 2 -LRB103 27415 DTM 53787 b

1    Sec. 10. Possession, self-administration, and use of
2epinephrine auto-injectors or inhalers at recreation camps and
3after-school care programs.
4    (a) A recreation camp or an after-school care program
5shall permit a child with severe, potentially life-threatening
6allergies to possess, self-administer, and use an epinephrine
7auto-injector or inhaler, if the following conditions are
8satisfied:
9        (1) The child has the written approval of his or her
10    parent or guardian.
11        (2) The recreational camp or after-school care program
12    administrator or, if a nurse is assigned to the camp or
13    program, the nurse shall receive copies of the written
14    approvals required under paragraph (1) of subsection (a)
15    of this Section.
16        (3) The child's parent or guardian shall submit
17    written verification confirming that the child has the
18    knowledge and skills to safely possess, self-administer,
19    and use an epinephrine auto-injector or inhaler in a camp
20    or an after-school care program setting.
21    (b) The child's parent or guardian shall provide the camp
22or program with the following information:
23        (1) the child's name;
24        (2) the name, route, and dosage of medication;
25        (3) the frequency and time of medication
26    administration or assistance;

 

 

HB2949 Enrolled- 3 -LRB103 27415 DTM 53787 b

1        (4) the date of the order;
2        (5) a diagnosis and any other medical conditions
3    requiring medications, if not a violation of
4    confidentiality or if not contrary to the request of the
5    parent or guardian to keep confidential;
6        (6) specific recommendations for administration;
7        (7) any special side effects, contraindications, and
8    adverse reactions to be observed;
9        (8) the name of each required medication; and
10        (9) any severe adverse reactions that may occur to
11    another child, for whom the epinephrine auto-injector or
12    inhaler is not prescribed, should the other child receive
13    a dose of the medication.
14    (c) If the conditions of this Act are satisfied, the child
15may possess, self-administer, and use an epinephrine
16auto-injector or inhaler at the camp or after-school care
17program or at any camp-sponsored or program-sponsored
18activity, event, or program.
19    (d) The recreational camp or after-school care program
20must inform the parents or guardians of the child, in writing,
21that the recreational camp or after-school care program and
22its employees and agents are to incur no liability, as
23applicable, except for willful and wanton conduct, as a result
24of any injury arising from the self-administration of
25medication to the child. The parents or guardians of the child
26must sign a statement acknowledging that the recreational camp

 

 

HB2949 Enrolled- 4 -LRB103 27415 DTM 53787 b

1or after-school care program is to incur no liability, except
2for willful and wanton conduct, as a result of any injury
3arising from the self-administration of medication by the
4child and that the parents or guardians must indemnify and
5hold harmless the recreational camp or after-school care
6program and its employees and agents, as applicable, against
7any claims, except a claim based on willful and wanton
8conduct, arising out of the self-administration of medication
9by the child.
10    (e) After-school care program personnel who have completed
11an anaphylaxis training program as identified under the
12Epinephrine Injector Act may administer an undesignated
13epinephrine injection to any child if the after-school care
14program personnel believe in good faith that the child is
15having an anaphylactic reaction while in the after-school care
16program. After-school care program personnel may carry
17undesignated epinephrine injectors on their person while in
18the after-school care program.
19    (f) After-school care program personnel may administer
20undesignated asthma medication to any child if the
21after-school care program personnel believe in good faith that
22the child is experiencing respiratory distress while in the
23after-school care program. After-school care program personnel
24may carry undesignated asthma medication on their person while
25in the after-school care program.
26    (g) If after-school care program personnel are to

 

 

HB2949 Enrolled- 5 -LRB103 27415 DTM 53787 b

1administer an undesignated epinephrine injection or an
2undesignated asthma medication to a child, the after-school
3care program personnel must inform the parents or guardians of
4the child, in writing, that the after-school care program and
5its employees and agents, acting in accordance with standard
6protocols and the prescription for the injection or
7medication, shall incur no liability, except for willful and
8wanton conduct, as a result of any injury arising from the
9administration of the injection or medication, notwithstanding
10whether authorization was given by the child's parents or
11guardians or by the child's physician, physician assistant, or
12advanced practice registered nurse. A parent or guardian of
13the child must sign a statement acknowledging that the
14after-school care program and its employees and agents are to
15incur no liability, except for willful and wanton conduct, as
16a result of any injury arising from the administration of the
17medication or injection, regardless of whether authorization
18was given by a parent or guardian of the child or by the
19child's physician, physician assistant, or advanced practice
20registered nurse, and that the parent or guardian must also
21indemnify and hold harmless the after-school care program and
22its employees and agents against any claims, except a claim
23based on willful and wanton conduct, arising out of the
24administration of the medication or injection, regardless of
25whether authorization was given by the child's parent or
26guardian or by the child's physician, physician assistant, or

 

 

HB2949 Enrolled- 6 -LRB103 27415 DTM 53787 b

1advanced practice registered nurse.
2    (h) If after-school care program personnel administer an
3undesignated epinephrine injection to a person and the
4after-school care program personnel believe in good faith the
5person is having an anaphylactic reaction or administer
6undesignated asthma medication to a person and believe in good
7faith the person is experiencing respiratory distress, then
8the after-school care program and its employees and agents,
9acting in accordance with standard protocols and the
10prescription for the injection or medication, shall not incur
11any liability or be subject to professional discipline, except
12for willful and wanton conduct, as a result of any injury
13arising from the use of the injection or medication,
14notwithstanding whether notice was given to or authorization
15was given by the child's parent or guardian or by the child's
16physician, physician assistant, or advanced practice
17registered nurse and notwithstanding the absence of the
18parent's or guardian's signed statement acknowledging release
19from liability.
20    (i) The changes made to this Section by this amendatory
21Act of the 103rd General Assembly apply to actions filed on or
22after the effective date of this amendatory Act of the 103rd
23General Assembly.
24(Source: P.A. 94-670, eff. 8-23-05.)
 
25    Section 99. Effective date. This Act takes effect upon
26becoming law.